Bridging the Gap: Enhancing Cancer Care for Underserved Populations With the Veris Health Cancer Care Platform

Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorVERIS HEALTH INC

About this trial

The proposed study aims to optimize and validate the Veris Cancer Care Platform for the needs of medically underserved cancer patients receiving outpatient cancer therapy. The Veris Health platform is a remote patient monitoring and communication system designed to bridge the gap between clinical visits and provide oncology care teams with objective data during high-risk periods.

This study will specifically focus on optimizing the Veris Health platform for patients with language barriers, limited access to technology, and socioeconomic disparities. By incorporating user-centered design and working closely with community health centers, the research team will ensure that the platform is culturally and linguistically appropriate, easy to use, and accessible for all patients.

The study will use a mixed-methods approach to validate the effectiveness of the optimized platform, including quantitative data analysis and qualitative interviews with patients and healthcare providers. The goal is to demonstrate the potential for the Veris Health platform to improve outcomes for vulnerable populations by reducing hospitalizations, emergency department visits, and the economic burden of cancer care.

Eligibility criteria

Qualifiers

Adults > 18 years old

Diagnosis of cancer

ECOG Performance Status of 0-2

Undergoing or initiating systemic anticancer therapy

Disqualifiers

None

Trial design

Treatments tested in this trial

  • Veris Health Inc. Application

Treatment groups

50 Participants
are divided into 1 treatment group

Sponsors and collaborators

VERIS HEALTH INC

Lead sponsor

National Institutes of Health (NIH)

Collaborator

National Institute on Minority Health and Health Disparities (NIMHD)

Collaborator